Kombinált interferon-ribavirin kezelés és a hepatocellularis carcinoma elo″fordulása

Translated title of the contribution: Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma

Research output: Contribution to journalArticle

Abstract

Hepatocellular carcinoma (HCC) is the sixth most common cause of cancer-related death worldwide. Primary hepatocellular carcinoma can be found most frequently (80-90%) in patients with liver cirrhosis. The most frequent causes of liver cirrhosis are chronic hepatitis B and C virus infections and chronic alcohol consumption. The treatment and elimination of the etiological factors decreases the risk of HCC. The authors summarize the literary data, where effect of modern antiviral treatment has been examined according to the occurrence of HCC. It can be stated, that the antiviral therapy (interferon and nucleoside analogues) is able to decrease the risk of HCC or the recurrence of the tumor after curative treatment of HCC, in case of non responder state, as well. Drugs used for the insurance of equilibrium in redox state can also help in the decrease of HCC risk.

Original languageHungarian
Pages (from-to)1177-1181
Number of pages5
JournalOrvosi Hetilap
Volume151
Issue number29
DOIs
Publication statusPublished - Jul 1 2010

Fingerprint

Ribavirin
Interferons
Hepatocellular Carcinoma
Liver Cirrhosis
Therapeutics
Antiviral Agents
Pharmaceutical Services Insurance
Chronic Hepatitis B
Chronic Hepatitis C
Virus Diseases
Nucleosides
Hepatitis B virus
Alcohol Drinking
Hepacivirus
Oxidation-Reduction
Neoplasms
Recurrence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kombinált interferon-ribavirin kezelés és a hepatocellularis carcinoma elo″fordulása. / Lengyel, G.; Fehér, J.

In: Orvosi Hetilap, Vol. 151, No. 29, 01.07.2010, p. 1177-1181.

Research output: Contribution to journalArticle

@article{46992cb39e404f988b95f4ae8657d271,
title = "Kombin{\'a}lt interferon-ribavirin kezel{\'e}s {\'e}s a hepatocellularis carcinoma elo″fordul{\'a}sa",
abstract = "Hepatocellular carcinoma (HCC) is the sixth most common cause of cancer-related death worldwide. Primary hepatocellular carcinoma can be found most frequently (80-90{\%}) in patients with liver cirrhosis. The most frequent causes of liver cirrhosis are chronic hepatitis B and C virus infections and chronic alcohol consumption. The treatment and elimination of the etiological factors decreases the risk of HCC. The authors summarize the literary data, where effect of modern antiviral treatment has been examined according to the occurrence of HCC. It can be stated, that the antiviral therapy (interferon and nucleoside analogues) is able to decrease the risk of HCC or the recurrence of the tumor after curative treatment of HCC, in case of non responder state, as well. Drugs used for the insurance of equilibrium in redox state can also help in the decrease of HCC risk.",
keywords = "alcohol, antiviral treatment, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, liver cirrhosis",
author = "G. Lengyel and J. Feh{\'e}r",
year = "2010",
month = "7",
day = "1",
doi = "10.1556/OH.2010.28925",
language = "Hungarian",
volume = "151",
pages = "1177--1181",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "29",

}

TY - JOUR

T1 - Kombinált interferon-ribavirin kezelés és a hepatocellularis carcinoma elo″fordulása

AU - Lengyel, G.

AU - Fehér, J.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Hepatocellular carcinoma (HCC) is the sixth most common cause of cancer-related death worldwide. Primary hepatocellular carcinoma can be found most frequently (80-90%) in patients with liver cirrhosis. The most frequent causes of liver cirrhosis are chronic hepatitis B and C virus infections and chronic alcohol consumption. The treatment and elimination of the etiological factors decreases the risk of HCC. The authors summarize the literary data, where effect of modern antiviral treatment has been examined according to the occurrence of HCC. It can be stated, that the antiviral therapy (interferon and nucleoside analogues) is able to decrease the risk of HCC or the recurrence of the tumor after curative treatment of HCC, in case of non responder state, as well. Drugs used for the insurance of equilibrium in redox state can also help in the decrease of HCC risk.

AB - Hepatocellular carcinoma (HCC) is the sixth most common cause of cancer-related death worldwide. Primary hepatocellular carcinoma can be found most frequently (80-90%) in patients with liver cirrhosis. The most frequent causes of liver cirrhosis are chronic hepatitis B and C virus infections and chronic alcohol consumption. The treatment and elimination of the etiological factors decreases the risk of HCC. The authors summarize the literary data, where effect of modern antiviral treatment has been examined according to the occurrence of HCC. It can be stated, that the antiviral therapy (interferon and nucleoside analogues) is able to decrease the risk of HCC or the recurrence of the tumor after curative treatment of HCC, in case of non responder state, as well. Drugs used for the insurance of equilibrium in redox state can also help in the decrease of HCC risk.

KW - alcohol

KW - antiviral treatment

KW - hepatitis B virus

KW - hepatitis C virus

KW - hepatocellular carcinoma

KW - liver cirrhosis

UR - http://www.scopus.com/inward/record.url?scp=77954466581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954466581&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28925

DO - 10.1556/OH.2010.28925

M3 - Article

VL - 151

SP - 1177

EP - 1181

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 29

ER -